Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $90,300 - $104,475
-2,500 Reduced 19.69%
10,200 $374,000
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $39,390 - $51,280
-1,000 Reduced 7.3%
12,700 $518,000
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $34,736 - $45,344
-832 Reduced 5.73%
13,700 $702,000
Q3 2022

Nov 08, 2022

BUY
$43.76 - $53.42 $635,920 - $776,299
14,532 New
14,532 $636,000
Q3 2019

Nov 04, 2019

SELL
$32.49 - $42.13 $159,201 - $206,437
-4,900 Closed
0 $0
Q2 2019

Jul 24, 2019

SELL
$36.98 - $41.52 $924 - $1,038
-25 Reduced 0.51%
4,900 $213,000
Q4 2018

Jan 24, 2019

SELL
$38.47 - $43.86 $961 - $1,096
-25 Reduced 0.51%
4,925 $215,000
Q3 2018

Oct 15, 2018

BUY
$34.47 - $41.81 $170,626 - $206,959
4,950 New
4,950 $218,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Delaney Dennis R Portfolio

Follow Delaney Dennis R and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delaney Dennis R, based on Form 13F filings with the SEC.

News

Stay updated on Delaney Dennis R with notifications on news.